- Investing Ideas
- U.S. Pharmaceuticals & Biotech Sustainable Track Record
U.S. Pharmaceuticals & Biotech Sustainable Track Record
Results
13
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
13 companies
CorMedix
Market Cap: US$587.6m
A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
CRMD
US$7.53
7D
-4.3%
1Y
-35.3%
Incyte
Market Cap: US$24.9b
A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.
INCY
US$119.52
7D
1.6%
1Y
58.1%
Protalix BioTherapeutics
Market Cap: US$182.9m
A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.
PLX
US$2.37
7D
0%
1Y
63.4%
CareDx
Market Cap: US$2.3b
Provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally.
CDNA
US$43.71
7D
17.7%
1Y
257.7%
Aurinia Pharmaceuticals
Market Cap: US$1.9b
A biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan.
AUPH
US$14.88
7D
-3.1%
1Y
41.8%
Rigel Pharmaceuticals
Market Cap: US$704.2m
A biotechnology company, develops and provides therapies that enhance the lives of patients with hematologic disorders and cancer in the United States.
RIGL
US$36.81
7D
0.2%
1Y
68.0%
ACADIA Pharmaceuticals
Market Cap: US$4.5b
A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.
ACAD
US$25.87
7D
4.1%
1Y
9.9%
Medpace Holdings
Market Cap: US$16.1b
Provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia.
MEDP
US$577.11
7D
-4.0%
1Y
36.4%
Exelixis
Market Cap: US$14.1b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$53.03
7D
-4.2%
1Y
42.3%
TG Therapeutics
Market Cap: US$7.6b
A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.
TGTX
US$52.03
7D
-7.2%
1Y
48.6%
Eli Lilly
Market Cap: US$1.0t
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.
LLY
US$1,148.84
7D
-3.9%
1Y
50.7%
Earth Science Tech
Market Cap: US$28.6m
Together with its subsidies, focuses on health and wellness industry.
ETST
US$0.11
7D
-8.4%
1Y
-43.6%
CapForce
Market Cap: US$113.4m
A precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally.
CFOR
US$9.16
7D
-49.1%
1Y
23,207.9%